SynthesisJournal of neurology2024

Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis.

Yahui Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.